Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia

Schizophrenia Research

Volumn 139, Issue 1-3, 2012, Pages 207-210

  Feifel, David ^a   MacDonald, Kai ^a   Cobb, Patrice ^a   Minassian, Arpi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cognition; CVLT; LNS; Memory; Oxytocin; Schizophrenia

Indexed keywords

OXYTOCIN; PLACEBO;

ARTICLE; CALIFORNIA VERBAL LEARNING TEST; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LETTER NUMBER SEQUENCE; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECALL; SCHIZOPHRENIA; TASK PERFORMANCE; TREATMENT OUTCOME; VERBAL MEMORY;

ADMINISTRATION, INTRANASAL; ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MEMORY DISORDERS; MENTAL RECALL; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OXYTOCIN; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; VERBAL LEARNING;

EID: 84863785836     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.05.018     Document Type: Article

References (19)

1. Ansseau M., Legros J.J., Mormont C., Cerfontaine J.L., Papart P., Geenen V., Adam F., Franck G. Intranasal oxytocin in obsessive-compulsive disorder. Psychoneuroendocrinology 1987, 12(3):231-236.
2. Bruins J., Hijman R., Van Ree J.M. Effect of a single dose of des-glycinamide-(Arg8)vasopressin or oxytocin on cognitive processes in young healthy subjects. Peptides 1992, 13(3):461-468.
3. Caldwell H.K., Stephens S.L., Young W.S. Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice. Mol. Psychiatry 2009, 14(2):190-196.
4. Delis D.C., Kramer J.H., Kaplan E., Ober B.A. The California Verbal Learning Test 2000, Psychological Corporation, San Antonio, Tx.
5. Fehm-Wolfsdorf G., Born J., Voigt K.H., Fehm H.L. Human memory and neurohypophyseal hormones: opposite effects of vasopressin and oxytocin. Psychoneuroendocrinology 1984, 9(3):285-292.
6. Feifel D., Reza T. Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating. Psychopharmacology (Berl.) 1999, 141(1):93-98.
7. Feifel D., Macdonald K., Nguyen A., Cobb P., Warlan H., Galangue B., Minassian A., Becker O., Cooper J., Perry W., Lefebvre M., Gonzales J., Hadley A. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol. Psychiatry 2010, 68(7):678-680.
8. Feifel D., Shilling P.D., Belcher A.M. The effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gating. Eur. Neuropsychopharmacol. 2012, 22(5):374-378.
9. Ferrier B.M., Kennett D.J., Devlin M.C. Influence of oxytocin on human memory processes. Life Sci. 1980, 27(24):2311-2317.
10. Heinrichs M., Meinlschmidt G., Wippich W., Ehlert U., Hellhammer D.H. Selective amnesic effects of oxytocin on human memory. Physiol. Behav. 2004, 83(1):31-38.
11. Herzmann G., Young B., Bird C.W., Curran T. Oxytocin can impair memory for social and non-social visual objects: a within-subject investigation of oxytocin's effects on human memory. Brain Res. 2012, 1451:65-73.
12. Kane J.M., Correll C.U. Past and present progress in the pharmacologic treatment of schizophrenia. J. Clin. Psychiatry 2010, 71(9):1115-1124.
13. O'Grada C., Dinan T. Executive function in schizophrenia: what impact do antipsychotics have?. Hum. Psychopharmacol. 2007, 22(6):397-406.
14. Pedersen C.A., Gibson C.M., Rau S.W., Salimi K., Smedley K.L., Casey R.L., Leserman J., Jarskog L.F., Penn D.L. Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia. Schizophr. Res. 2011, 132(1):50-53.
15. Stone W.S., Giuliano A.J., Tsuang M.T., Braff D.L., Cadenhead K.S., Calkins M.E., Dobie D.J., Faraone S.V., Freedman R., Green M.F., Greenwood T.A., Gur R.E., Gur R.C., Light G.A., Mintz J., Nuechterlein K.H., Olincy A., Radant A.D., Roe A.H., Schork N.J., Siever L.J., Silverman J.M., Swerdlow N.R., Thomas A.R., Tsuang D.W., Turetsky B.I., Seidman L.J. Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophr. Res. 2011, 128(1-3):102-110.
16. Striepens N., Kendrick K.M., Maier W., Hurlemann R. Prosocial effects of oxytocin and clinical evidence for its therapeutic potential. Front. Neuroendocrinol. 2011, 32(4):426-450.
17. Van Snellenberg J.X. Working memory and long-term memory deficits in schizophrenia: is there a common substrate?. Psychiatry Res. 2009, 174(2):89-96.
18. Wechsler D. Wechsler Adult Intelligence Scale Third Edition (WAIS-III) 1997, Psychological Corporation, San Antonio.
19. Woods S.P., Delis D.C., Scott J.C., Kramer J.H., Holdnack J.A. The California Verbal Learning Test-second edition: test-retest reliability, practice effects, and reliable change indices for the standard and alternate forms. Arch. Clin. Neuropsychol. 2006, 21(5):413-420.